Scandinavian Journal of Rheumatology

Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability, and low bioavailable insulin-like growth factor
pp. 321-328(8)
Authors: Engvall, I-L.; Elkan, A-C.; Tengstrand, B.; Cederholm, T.; Brismar, K.; Hafstrom, I.

Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis
pp. 329-336(8)
Authors: Abdel-Nasser, A. M.; Mahmoud, M. H.; El Mansoury, T. M.; Osman, A. M.

The relationship between anti-cyclic citrullinated peptide and bone mineral density and radiographic damage in patients with rheumatoid arthritis
pp. 337-342(6)
Authors: Guler, H.; Turhanoglu, A. D.; Ozer, B.; Ozer, C.; Balci, A.

Stability of the upper neck during isometric neck exercises in rheumatoid arthritis patients with atlantoaxial disorders
pp. 343-347(5)
Authors: Hakkinen, A.; Makinen, H.; Ylinen, J.; Hannonen, P.; Sokka, T.; Neva, M.; Kautiainen, H.; Kauppi, M.

Prevalence and patterns of anti-nuclear antibodies in Korean children with juvenile idiopathic arthritis according to ILAR criteria
pp. 348-351(4)
Authors: Shin, J. I.; Kim, K. H.; Chun, J. K.; Lee, T. J.; Kim, K. J.; Kim, H. S.; Kim, D. S.

Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus
pp. 352-359(8)
Authors: Svenungsson, E.; Cederholm, A.; Jensen-Urstad, K.; Fei, G. -Z.; de Faire, U.; Frostegård, J.

Clinical characteristics of patients with both anti-U1RNP and anti-centromere antibodies
pp. 360-364(5)
Authors: Takada, K.; Suzuki, K.; Matsumoto, M.; Okada, M.; Nakanishi, T.; Horikoshi, H.; Higuchi, T.; Ohsuzu, F.

Hypogonadism in Wegener's granulomatosis
pp. 365-369(5)
Authors: Richter, J. G.; Becker, A.; Specker, C.; Schneider, M.

Molecular analysis of MEFV gene mutations among Palestinian patients with Behcet's disease
pp. 370-374(5)
Authors: Ayesh, S.; Abu-Rmaileh, H.; Nassar, S.; Al-Shareef, W.; Abu-Libdeh, B.; Muhanna, A.; Al-Kafri, F.

Degenerative and traumatic changes in the lower cervical spine facet joints
pp. 375-384(10)
Authors: Uhrenholt, L.; Hauge, E.; Charles, A. Vesterby; Gregersen, M.

Good response to IL-1β blockade by anakinra in a 23-year-old CINCA/NOMID patient without mutations in the CIAS1 gene. Cytokine profiles and functional studies
pp. 385-389(5)
Authors: Hedrich, C. M.; Fiebig, B.; Sallmann, S.; Bruck, N.; Hahn, G.; Roesler, J.; Roesen-Wolff, A.; Heubner, G.; Gahr, M.

A case of Evans syndrome combined with systemic lupus erythematosus successfully treated with rituximab
pp. 390-393(4)
Authors: Kittaka, K.; Dobashi, H.; Baba, N.; Iseki, K.; Kameda, T.; Susaki, K.; Kitanaka, A.; Kubota, Y.; Ishida, T.

Paediatric contracturing granulomatous myositis
pp. 394-395(2)
Authors: Bowers, B.; Patel, A. M.; Mirza, N.; Seidman, R. J.

Can sonography be used to predict the response to intra-articular corticosteroid injection in primary osteoarthritis of the knee?
pp. 395-397(3)
Authors: Pendleton, A.; Millar, A.; O'Kane, D.; Wright, G. D.; Taggart, A. J.

Multiple sclerosis following etanercept treatment for ankylosing spondylitis
pp. 397-399(3)
Authors: Pfueller, C. F.; Seipelt, E.; Zipp, F.; Paul, F.

Efficacy of adalimumab, etanercept, and infliximab in psoriatic arthritis based on ACR50 response after 24 weeks of treatment
pp. 399-400(2)
Authors: Brodszky, V.; Pentek, M.; Gulacsi, L.

ERRATUM
pp. 400-400(1)